These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10514516)

  • 1. Expression of a dominant negative SHP-2 in transgenic mice induces insulin resistance.
    Maegawa H; Hasegawa M; Sugai S; Obata T; Ugi S; Morino K; Egawa K; Fujita T; Sakamoto T; Nishio Y; Kojima H; Haneda M; Yasuda H; Kikkawa R; Kashiwagi A
    J Biol Chem; 1999 Oct; 274(42):30236-43. PubMed ID: 10514516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for protein-tyrosine phosphatase SHP-2 in insulin-induced activation of c-Jun NH(2)-terminal kinase.
    Fukunaga K; Noguchi T; Takeda H; Matozaki T; Hayashi Y; Itoh H; Kasuga M
    J Biol Chem; 2000 Feb; 275(7):5208-13. PubMed ID: 10671568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel roles of liver for compensation of insulin resistance in human growth hormone transgenic rats.
    Cho Y; Ariga M; Uchijima Y; Kimura K; Rho JY; Furuhata Y; Hakuno F; Yamanouchi K; Nishihara M; Takahashi S
    Endocrinology; 2006 Nov; 147(11):5374-84. PubMed ID: 16916956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases.
    Shi ZQ; Lu W; Feng GS
    J Biol Chem; 1998 Feb; 273(9):4904-8. PubMed ID: 9478933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
    Matsubara H; Shibasaki Y; Okigaki M; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1085-91. PubMed ID: 11302725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action.
    Zabolotny JM; Haj FG; Kim YB; Kim HJ; Shulman GI; Kim JK; Neel BG; Kahn BB
    J Biol Chem; 2004 Jun; 279(23):24844-51. PubMed ID: 15031294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent roles of SHP-2 in ERK activation by leptin receptors.
    Bjørbaek C; Buchholz RM; Davis SM; Bates SH; Pierroz DD; Gu H; Neel BG; Myers MG; Flier JS
    J Biol Chem; 2001 Feb; 276(7):4747-55. PubMed ID: 11085989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats.
    Ogihara T; Asano T; Ando K; Chiba Y; Sekine N; Sakoda H; Anai M; Onishi Y; Fujishiro M; Ono H; Shojima N; Inukai K; Fukushima Y; Kikuchi M; Fujita T
    Diabetes; 2001 Mar; 50(3):573-83. PubMed ID: 11246877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis.
    Dubois MJ; Bergeron S; Kim HJ; Dombrowski L; Perreault M; Fournès B; Faure R; Olivier M; Beauchemin N; Shulman GI; Siminovitch KA; Kim JK; Marette A
    Nat Med; 2006 May; 12(5):549-56. PubMed ID: 16617349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shp-2 specifically regulates several tyrosine-phosphorylated proteins in brain-derived neurotrophic factor signaling in cultured cerebral cortical neurons.
    Araki T; Yamada M; Ohnishi H; Sano S; Uetsuki T; Hatanaka H
    J Neurochem; 2000 Feb; 74(2):659-68. PubMed ID: 10646517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance.
    Zabolotny JM; Kim YB; Peroni OD; Kim JK; Pani MA; Boss O; Klaman LD; Kamatkar S; Shulman GI; Kahn BB; Neel BG
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5187-92. PubMed ID: 11309481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the protein tyrosine phosphatase SHP-1 increases glucose uptake in skeletal muscle cells by augmenting insulin receptor signaling and GLUT4 expression.
    Bergeron S; Dubois MJ; Bellmann K; Schwab M; Larochelle N; Nalbantoglu J; Marette A
    Endocrinology; 2011 Dec; 152(12):4581-8. PubMed ID: 21952243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
    Frearson JA; Alexander DR
    J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src homology region 2 domain-containing phosphatase 1 positively regulates B cell receptor-induced apoptosis by modulating association of B cell linker protein with Nck and activation of c-Jun NH2-terminal kinase.
    Mizuno K; Tagawa Y; Mitomo K; Watanabe N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2002 Jul; 169(2):778-86. PubMed ID: 12097380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive regulation of c-Jun N-terminal kinase and TNF-alpha production but not histamine release by SHP-1 in RBL-2H3 mast cells.
    Xie ZH; Zhang J; Siraganian RP
    J Immunol; 2000 Feb; 164(3):1521-8. PubMed ID: 10640770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection.
    Zhang J; Somani AK; Yuen D; Yang Y; Love PE; Siminovitch KA
    J Immunol; 1999 Sep; 163(6):3012-21. PubMed ID: 10477564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.